{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:26:32Z","timestamp":1794212792695,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.psychres.2026.117010","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:04:46Z","timestamp":1770969886000},"page":"117010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones"],"prefix":"10.1016","volume":"359","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-4346","authenticated-orcid":false,"given":"Sean P.","family":"Goldy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Sepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha N.","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal A.","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-1644","authenticated-orcid":false,"given":"Albert","family":"Garcia-Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gukasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-3237","authenticated-orcid":false,"given":"Frederick S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-6227","authenticated-orcid":false,"given":"David B.","family":"Yaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep M.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.psychres.2026.117010_bib0001","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0002","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2026.117010_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"issue":"3","key":"10.1016\/j.psychres.2026.117010_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2026.117010_bib0005","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1471082X0100100202","article-title":"Multiple membership multiple classification (MMMC) models","volume":"1","author":"Browne","year":"2001","journal-title":"Stat. Model."},{"issue":"12","key":"10.1016\/j.psychres.2026.117010_bib0007","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-017-4769-4","article-title":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences","volume":"235","author":"Carbonaro","year":"2018","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2026.117010_bib0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.psychres.2026.117010_bib0009","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus Escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.psychres.2026.117010_bib0015","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D\u2019Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.psychres.2026.117010_bib0011","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/0269881120916143","article-title":"Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: phenomenology, interpretation, and enduring effects","volume":"34","author":"Davis","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117010_bib0012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0269881120967878","article-title":"Development of the psychological insight questionnaire among a sample of people who have consumed psilocybin or LSD","volume":"35","author":"Davis","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117010_bib0013","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72678-4","article-title":"Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients","volume":"14","author":"de Beer","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2026.117010_bib71","unstructured":"Ehrenkranz, R., Sepeda, N.D., Yaden, D.B., Barrett, F.S. (in prep). Psilocybin enhances the experience and practice of meditation in long-term meditators."},{"issue":"5","key":"10.1016\/j.psychres.2026.117010_bib0016","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/cpp.2461","article-title":"Therapist effects vary significantly across psychological treatment care sectors","volume":"27","author":"Firth","year":"2020","journal-title":"Clin. Psychol. Psychother."},{"issue":"3","key":"10.1016\/j.psychres.2026.117010_bib0017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2015","journal-title":"Curr. Drug Abuse Rev."},{"issue":"9","key":"10.1016\/j.psychres.2026.117010_bib0018","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/09567976221085501","article-title":"The social effects of an awesome solar eclipse","volume":"33","author":"Goldy","year":"2022","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.psychres.2026.117010_bib0019","first-page":"1","article-title":"Considering distinct positive emotions in psychedelic science","author":"Goldy","year":"2024","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117010_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/02698811241292951","article-title":"Psychedelic risks and benefits: a cross-sectional survey study","author":"Goldy","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"18","key":"10.1016\/j.psychres.2026.117010_bib0023","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u2018assist psychotherapy\u2019?","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117010_bib0022","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jad.2024.12.061","article-title":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","volume":"372","author":"Goodwin","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117010_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117010_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2026.117010_bib0024","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117010_bib0026","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.psychres.2026.117010_bib0027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117010_bib0032","unstructured":"Gukasyan N., Schreyer C., Cosimano M.P., et al. (in prep) Psilocybin-assisted therapy for Anorexia Nervosa: a multi-session open-label pilot study. Epub ahead of print in prep."},{"key":"10.1016\/j.psychres.2026.117010_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2024.2546","article-title":"Adverse events in studies of classic psychedelics: a systematic review and meta-analysis","author":"Hinkle","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117010_bib0034","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2026.117010_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cpr.2018.08.004","article-title":"A systematic review of therapist effects: a critical narrative update and refinement to Baldwin and Imel\u2019s (2013) review","volume":"67","author":"Johns","year":"2019","journal-title":"Clin. Psychol. Rev."},{"issue":"11","key":"10.1016\/j.psychres.2026.117010_bib0036","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"Suppl 4","key":"10.1016\/j.psychres.2026.117010_bib0038","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/schbul\/sbu012","article-title":"Culture and hallucinations: overview and Future directions","volume":"40","author":"Lar\u00f8i","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0039","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1038\/s41598-022-11999-8","article-title":"Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience","volume":"12","author":"Lawrence","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.psychres.2026.117010_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300501","article-title":"The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder","volume":"19","author":"Levin","year":"2024","journal-title":"PLOS One"},{"issue":"11","key":"10.1016\/j.psychres.2026.117010_bib0041","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0042","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/ajp.126.1.59","article-title":"A clinical study of LSD treatment in alcoholism","volume":"126","author":"Ludwig","year":"1969","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117010_bib0043","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","article-title":"Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin","volume":"51","author":"Maclean","year":"2012","journal-title":"J. Sci. Study Relig."},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0044","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2006.01.020","article-title":"Psychiatrist effects in the psychopharmacological treatment of depression","volume":"92","author":"McKay","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117010_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic Alliance and Rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117010_bib0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: a systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117010_bib0047","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/a-1312-7297","article-title":"Psychedelics and psychotherapy","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0048","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not Be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.psychres.2026.117010_bib0049","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2026.117010_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1133414","article-title":"A phase 1\/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression","volume":"14","author":"Reckweg","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117010_bib0051","doi-asserted-by":"crossref","DOI":"10.1089\/psymed.2024.0026","article-title":"What is psychological support in the context of psychedelic clinical trials?","author":"Richard","year":"2025","journal-title":"Psychedelic Med."},{"key":"10.1016\/j.psychres.2026.117010_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103149","article-title":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","volume":"82","author":"Rieser","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.psychres.2026.117010_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2026.117010_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2026.117010_bib0055","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the Emotional breakthrough inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2026.117010_bib0056","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2026.117010_bib0057","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117010_bib0058","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.psychres.2026.117010_bib0059","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10488-016-0750-5","article-title":"The relationship between therapist effects and therapy delivery factors: therapy modality, dosage, and non-completion","volume":"44","author":"Saxon","year":"2017","journal-title":"Adm. Policy Ment. Health"},{"key":"10.1016\/j.psychres.2026.117010_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0061","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/02698811231199112","article-title":"The revival of the psychedelic experience scale: revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies","volume":"38","author":"Stocker","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2026.117010_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2026.117010_bib0064","author":"van Paridon"},{"key":"10.1016\/j.psychres.2026.117010_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2021.684768","article-title":"Healing in a social context: the importance of clinician and patient relationship","volume":"2","author":"Wampold","year":"2021","journal-title":"Front. Pain Res."},{"issue":"21","key":"10.1016\/j.psychres.2026.117010_bib0066","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s00213-014-3570-x","article-title":"MDMA alters emotional processing and facilitates positive social interaction","volume":"231","author":"Wardle","year":"2014","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.psychres.2026.117010_bib0067","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00213-022-06187-5","article-title":"The Watts connectedness scale: a new scale for measuring a sense of connectedness to self, others, and world","volume":"239","author":"Watts","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2026.117010_bib0068","doi-asserted-by":"crossref","DOI":"10.1007\/s11469-024-01253-9","article-title":"Unique psychological mechanisms underlying psilocybin therapy versus Escitalopram treatment in the treatment of major depressive disorder","author":"Weiss","year":"2024","journal-title":"Int. J. Ment. Health Addict."},{"issue":"2","key":"10.1016\/j.psychres.2026.117010_bib0069","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.psychres.2026.117010_bib0070","first-page":"1","article-title":"Clinically relevant acute subjective effects of psychedelics beyond mystical experience","author":"Yaden","year":"2024","journal-title":"Nat. Rev. Psychol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:12:05Z","timestamp":1794211925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":70,"alternative-id":["S0165178126000715"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117010","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117010"}}